Why Nutex Health Inc.’s (NUTX) Stock Is Up 6.12%
As of Friday, September 25, Nutex Health Inc.’s NUTX share price has surged by 6.12%, which has investors questioning if this is right time to sell.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Michael Rose
Michael Rose
Rosalio Madrigal
Michael Rose
Jenna Brashear
| Share Statistics | NUTX | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,412.7 | $1,631.5 | 50% |
|
| Shares Out (Mil) | 7.0 | 77.7 | 17% |
|
| Institutional Ownership | 52.2% | 87.7% | 36% |
|
| Float (Mil) | 4.1 | 55.9 | 10% |
|
| Beta | 1.99 | 0.81 | 92% |
|
| Avg Daily Volume (000s) | 174 | 539 | 42% |
|
| Price Change (52-week) |
100.8% | 78.8% | 94% |
|
| Growth | NUTX | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 26.1% | 10.6% | 87% |
|
| Net Income (5yr) | (7.8%) | (0.3%) | 31% |
|
| EPS (5yr) | (17.1%) | 3.0% | 16 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 38.7% | (17.3%) | 90% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | $4.954 | $27.794 | $27.872 | |
| Month Ago EPS | na | na | na | |
| # Rev Up | 0 | 1 | 0 | |
| # Rev Down | 0 | 0 | 1 | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | (47.2%) | 165.2% | 141.8% | |
| Financials | NUTX | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $847 | $1,505 | 48% |
|
| Net Income (TTM) (Mil) | $180 | $26 | 67% |
|
| EPS (TTM) | $26.346 | $0.200 | 99% |
|
| Operating Cash Flow (TTM) (Mil) | $280 | $157 | 63% |
|
| Net Cash Flow (TTM) (Mil) | $110 | $2 | 78% |
|
| Long-Term Debt (Q1) (Mil) | $329 | $374 | 54% |
|
| Enterprise Value (Q1) (Mil) | $1,528 | $2,284 | 46% |
|
| Valuation | NUTX | Industry Median |
Percentile (All Stocks) |
|
| P/B | 3.58 | 2.93 | 72% |
|
| P/E | 8.2 | 25.2 | 12% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | NUTX | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 54.5% | 27.6% | 66% |
|
| Net Margin | 21.2% | 1.2% | 80% |
|
| ROA | 19.9% | 2.1% | 96% |
|
| ROE | 57.2% | 6.9% | 94% |
|
| Liabilities to Assets | 47.4% | 60.8% | 39% |
|
| F-Score | 6 | 5 | 67% |
|
Passing Stock Screens
As of 10/9/2026, from a list of 60 stock screening strategies,
| Performance Since Inception: | 7.0% |
| +/- S&P 500: | -0.5 |
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors